NanoViricides Inc. (NNVC)

[arvitar]

- Moffat hasn't had any work published from her own lab as senior/corresponding author since 2014, and the most recent one prior that was in 2010, which is horrifically poor productivity for any Principle Investigator wanting to keep their job in science these days.
https://www.ncbi.nlm.nih.gov/pubmed/?term=moffat-jf

i.e. Most competitive labs publish at least a couple decent papers every year if they are very small.

- She has never been awarded her own NIH RO1 grant, which is the current minimal standard for being considered competitive in one's field.
https://projectreporter.nih.gov/reporter_searchresults.cfm

- Her best publications are the ones she coauthored as a trainee in the lab run by her mentor at Stanford.

- She is supported by one NIH contract, which is not a research grant, and runs out this summer.

Anyone arguing she is some kind widely respected star in her field doesn't know what they're talking about. I'm sure her colleagues think she's okay, but she's never managed to be an independently RO1-funded principle investigator, which is the minimal threshold of "success" in academic science. She hasn't published papers from her own lab in years, which is below the minimal standard to be considered an active researcher.

She's one of the many low-productivity scientists trying to survive in academia on whatever they can get for funding, which currently includes some small fee-for-service contract from Seymour.